Afanasyeva, Nadezda – Trademark Portfolio
Entity Type: 01
Afanasyeva, Nadezda has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 60% registration rate. The portfolio includes marks such as EYE DESIGN and EYE DESIGN NEW YORK. Filings span 3 Nice Classification classes, with the highest activity in Class 41 (Education & Entertainment) and Class 44 (Medical Services). This trademark owner is based in New York, NY.
31 E 32nd St, #510
New York, NY 10016
Showing of trademarks Trademarks
Trademark Classifications
Afanasyeva, Nadezda's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Afanasyeva, Nadezda have?
Afanasyeva, Nadezda has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does Afanasyeva, Nadezda file in?
Afanasyeva, Nadezda files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 3 (Cosmetics & Cleaning). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Afanasyeva, Nadezda's most well-known trademarks?
Afanasyeva, Nadezda's registered trademark portfolio includes well-known marks such as EYE DESIGN and EYE DESIGN NEW YORK. These are among 3 currently registered trademarks in the portfolio.
What is Afanasyeva, Nadezda's trademark registration success rate?
Afanasyeva, Nadezda has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.